TY - JOUR
T1 - Seventy-two hour gas exchange performance and hemodynamic properties of NOVALUNG®iLA as a gas exchanger for arteriovenous carbon dioxide removal
AU - Zhou, Xiaoqin
AU - Loran, David B.
AU - Wang, Dongfang
AU - Hyde, Brannon R.
AU - Lick, Scott D.
AU - Zwischenberger, Joseph B.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2005
Y1 - 2005
N2 - Objective: Acute respiratory failure is complicated by acidosis and altered end-organ perfusion. NOVA-LUNG®iLA is an interventional lung assist (ILA) device for arteriovenous carbon dioxide removal (AVCO2R). The present study was conducted to evaluate the device for short-term CO2 removal performance and hemodynamic response. Methods: Six adult sheep received cannulation of the jugular vein and carotid artery. The ILA-AVCO2R circuit was placed on the sheep for 72 hours. Hemodynamics and PaCO2 were measured; CO2 removal was calculated while varying sweep gas flow rates (Qg), device blood flow rates (Qb), and PaCO2. Results: Hemodynamic variables remained normal throughout the 72 hour study. CO2 removal increased with increases in Qg or Qb. Mean CO2 removal was 119.3 ml/min for Qb 1 L/min, Qg 5 L/min, and PaCO2 40-50 mmHg. PaCO2 was directly proportional to CO2 clearance (R=0.72, p <0.001). Conclusion: NOVALUNG®iLA can provide near total CO2 removal with Qb 1-2 L/min, Qg 5 L/min, and minimal flow resistance (3.88±0.82 mmHg/L/min). PaCO2, correlates with CO2 removal and is dependent on Qb and Qg.
AB - Objective: Acute respiratory failure is complicated by acidosis and altered end-organ perfusion. NOVA-LUNG®iLA is an interventional lung assist (ILA) device for arteriovenous carbon dioxide removal (AVCO2R). The present study was conducted to evaluate the device for short-term CO2 removal performance and hemodynamic response. Methods: Six adult sheep received cannulation of the jugular vein and carotid artery. The ILA-AVCO2R circuit was placed on the sheep for 72 hours. Hemodynamics and PaCO2 were measured; CO2 removal was calculated while varying sweep gas flow rates (Qg), device blood flow rates (Qb), and PaCO2. Results: Hemodynamic variables remained normal throughout the 72 hour study. CO2 removal increased with increases in Qg or Qb. Mean CO2 removal was 119.3 ml/min for Qb 1 L/min, Qg 5 L/min, and PaCO2 40-50 mmHg. PaCO2 was directly proportional to CO2 clearance (R=0.72, p <0.001). Conclusion: NOVALUNG®iLA can provide near total CO2 removal with Qb 1-2 L/min, Qg 5 L/min, and minimal flow resistance (3.88±0.82 mmHg/L/min). PaCO2, correlates with CO2 removal and is dependent on Qb and Qg.
UR - http://www.scopus.com/inward/record.url?scp=29244443388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=29244443388&partnerID=8YFLogxK
U2 - 10.1191/0267659105pf838oa
DO - 10.1191/0267659105pf838oa
M3 - Article
C2 - 16363314
AN - SCOPUS:29244443388
SN - 0267-6591
VL - 20
SP - 303
EP - 308
JO - Perfusion
JF - Perfusion
IS - 6
ER -